Journal Am Soc Echocardiography
- The Efficacy of Goal-Directed Valsalva to Elicit Clinically Significant Gradients in Patients with Obstructive Hypertrophic Cardiomyopathy taking Mavacamten Therapyby Cody Frye, Melissa Escudero, William Saunders, Olafunke Ajijola, George Mawardi, Shuktika Nandkeolyar, Noreen Kelly, Dermot Phelan on October 12, 2024 at 12:00 am
- Early Heart Checks: Harnessing Fetal Echocardiography, Genetic Insights, and the Role of Transvaginal Cardiac Imaging in Clinical Practiceby Flora Nuñez Gallegos, Anita J. Moon-Grady on October 11, 2024 at 12:00 am
- Reduction of Coronary Flow Velocity Reserve as the Main Driver of Prognostically Beneficial Coronary Revascularizationby Lauro Cortigiani, Nicola Gaibazzi, Quirino Ciampi, Fausto Rigo, Domenico Tuttolomondo, Francesco Bovenzi, Dario Gregori, Scipione Carerj, Mauro Pepi, Patricia A. Pellikka, Eugenio Picano, on behalf of the Stress Echo 2030 study group on October 8, 2024 at 12:00 am
Regional wall motion abnormality (RWMA) can be absent during stress echocardiography (SE) in patients with chronic coronary syndromes (CCS) and angiographically significant coronary artery disease (CAD) despite a reduction of coronary flow velocity reserve (CFVR).
- Sustained Benefits of Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy: Long-term Assessment Using AI-ECG and Echocardiographic Databy Mustafa Suppah, Hesham Abdalla, Kaitlin Roehl, Juan Farina, Reza Arsanjani, Jeffrey Geske, Steve Ommen, Said Alsidawi on October 8, 2024 at 12:00 am
- Left atrial function and incident heart failure in older adultsby Carlo Mannina, Kazato Ito, Zhezhen Jin, Yuriko Yoshida, Cesare Russo, Koki Nakanishi, Tatjana Rundek, Shunichi Homma, Mitchell S.V. Elkind, Marco R. Di Tullio on October 8, 2024 at 12:00 am
Heart failure (HF) prevalence is increasing, especially among older adults. Left atrial (LA) dysfunction is often associated with HF, but it is unclear whether it may contribute to its development. We investigated whether measures of LA function can predict the development of HF in older adults without history of cardiovascular events
- Continuing Education and Meeting Calendaron October 7, 2024 at 12:00 am
The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASE recognizes courses as supplements to formal training in an established echocardiographic laboratory. For more information about a course, please call the number listed. To list a course in the Continuing Education and […]
- Continuing Education and Meeting Calendaron October 1, 2024 at 12:00 am
The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASE recognizes courses as supplements to formal training in an established echocardiographic laboratory. For more information about a course, please call the number listed. To list a course in the Continuing Education and […]
- Highlights From the 35th Annual ASE Scientific Sessions, June 14 to 16, 2024 — Portland, Oregonon October 1, 2024 at 12:00 am
- Who are We and Where are We Going?by Theodore Abraham on October 1, 2024 at 12:00 am
“Do the difficult things while they are easy and do the great things while they are small.”Lao Tzu (Laozi)1
- Table of Contentson October 1, 2024 at 12:00 am
- Information for Readerson October 1, 2024 at 12:00 am
- Editorial Boardon October 1, 2024 at 12:00 am